VIP peptide: separating vasoactive intestinal peptide facts from TikTok hype

A recent TikTok video from Code:GINA at Peptira describes vasoactive intestinal peptide (VIP) as a 28-amino acid neuropeptide with powerful vasodilatory, smooth muscle relaxant, and immune-regulating effects. The clip emphasizes its production in the gut, pancreas, and brain, and mentions roles in digestion, blood pressure, and inflammation. While these statements align with textbook descriptions, the video’s brevity leaves out critical context about research limitations, delivery challenges, and the difference between endogenous physiology and exogenous peptide use.

What the clip claims

The video presents VIP as a multi-functional peptide that relaxes blood vessels, eases smooth muscle contraction, and modulates immune responses. It also implies that because VIP is naturally produced in the body, supplementing with it could offer broad benefits—from lowering blood pressure to reducing inflammation. The caption’s hashtags (#chroniccough, #peptide) hint at potential applications for respiratory or inflammatory conditions, though the clip itself does not detail any specific clinical evidence.

What the research actually covers

VIP is a well-studied neuropeptide with established roles in the enteric nervous system, where it regulates gastrointestinal motility and secretion. It also acts as a vasodilator in several vascular beds and has demonstrated anti-inflammatory properties in preclinical models, particularly by modulating cytokine release and promoting regulatory T-cell activity. Research has explored VIP in conditions like inflammatory bowel disease, rheumatoid arthritis, and pulmonary hypertension, but most studies are in animal models or early-phase human trials.

Importantly, VIP’s half-life in circulation is very short—on the order of minutes—which limits its therapeutic potential. Researchers have therefore developed stable analogs or delivery systems, but these are not the same as the native peptide. The clip does not mention this fundamental challenge.

Limits and missing context

A 15-second clip cannot convey the complexity of VIP biology. For instance, VIP’s effects are dose-dependent and tissue-specific; it can be pro- or anti-inflammatory depending on the microenvironment. Its vasodilatory action may lower blood pressure, but in healthy individuals, this could cause unwanted hypotension. Moreover, the clip does not clarify that VIP is not an approved drug for any indication—it is a research compound. The distinction between endogenous function and exogenous supplementation is crucial: injecting a peptide that your body already produces does not automatically amplify its benefits and may disrupt feedback loops.

Additionally, the clip’s reference to chronic cough is not supported by robust clinical evidence. While VIP has been investigated for airway diseases like asthma and COPD, results are preliminary. No large-scale, peer-reviewed trials have confirmed VIP as a treatment for chronic cough.

Mapping to catalog compounds

VIP itself is not listed in the peptides-pro catalog. However, the catalog includes several peptides that interact with similar pathways or are used in related research areas. For example, BPC-157 and TB-500 (Thymosin Beta-4) are studied for tissue repair and anti-inflammatory effects, though their mechanisms differ from VIP. Selank and Semax are neuropeptides with potential modulatory effects on the nervous and immune systems. Researchers interested in VIP-like activity might also explore ARA-290, a peptide derived from erythropoietin that has shown anti-inflammatory and neuroprotective properties in preclinical studies. None of these are substitutes for VIP, but they represent the breadth of peptide research available.

Research-use caveat

All peptides sold by peptides-pro are intended for laboratory research and in vitro studies only—not for human or animal use. The claims in the TikTok video are educational in nature but should not be interpreted as medical advice or as an endorsement for self-administration. Researchers must verify purity, stability, and ethical compliance before using any peptide in experiments.